The Clinical Value of Novel Inflammatory Biomarkers for Predicting Mycoplasma pneumoniae Infection in Children

Liqun Shao1, Bohai Yu1, Ying Lyu1

  • 1Department of Medical Laboratory, Shenzhen Hospital (Futian) of Guangzhou University of Chinese Medicine, Shenzhen, People's Republic of China.

Abstract

Insights

Novel inflammatory biomarkers like the system inflammation response index (SIRI) show promise for diagnosing Mycoplasma pneumoniae (MP) infections in children. These markers, derived from complete blood counts, offer new auxiliary diagnostic tools for community-acquired pneumonia caused by MP.

Area of Science:

  • Pediatric Infectious Diseases
  • Hematology
  • Diagnostic Biomarkers

Background:

  • Mycoplasma pneumoniae (MP) is a significant cause of community-acquired pneumonia (CAP) in children.
  • Accurate and timely diagnosis of MP infections presents challenges.
  • Novel inflammatory biomarkers require evaluation for their diagnostic utility.

Purpose of the Study:

  • To assess the diagnostic value of neutrophil-to-lymphocyte ratio (NLR), monocyte-to-lymphocyte ratio (MLR), platelet-to-lymphocyte ratio (PLR), systemic immune-inflammation index (SII), and system inflammation response index (SIRI) in pediatric MP infections.
  • To identify reliable inflammatory markers for aiding MP diagnosis in children.

Main Methods:

  • Complete blood count (CBC) data from 424 children with MP infection and 150 healthy children were analyzed.
  • Calculation of NLR, MLR, PLR, SII, and SIRI.
  • Statistical analysis including logistic regression and ROC curve analysis to determine predictive values.

Main Results:

  • Children with MP infection showed significantly higher WBC, NEU, MON, NLR, MLR, PLR, SII, and SIRI compared to controls.
  • MLR and SIRI were identified as major risk factors for MP infection in children via multivariate logistic regression.
  • A logistic regression model using MLR and SIRI achieved 83.28% predictive accuracy, with SIRI demonstrating a high AUC of 0.892.

Conclusions:

  • Novel inflammatory biomarkers, particularly SIRI and MLR, are significant in pediatric MP infections.
  • These biomarkers can serve as valuable auxiliary diagnostic indicators for MP infection in children.
  • The findings support the integration of these markers into diagnostic strategies for pediatric CAP.